Senate ADAP funding bill to hit floor Sept. 2 as part of Labor/HHS Appropriations bill.
SENATE ADAP FUNDING BILL TO HIT FLOOR SEPT. 2 as part of the Labor & HHS appropriations bill scheduled for floor consideration following the August Congressional recess. The House Labor/HHS appropriations bill is scheduled to reach the floor the second week of September. The Senate bill (S 1061) allocates $217 mil. for AIDS Drug Assistance Programs, while the House bill (HR 2264) affords ADAPs with $299 mil. While both appropriations are substantially higher than the Clinton Administration's FY 1998 budget request of $167 mil. for the program, the Administration is supporting the higher amount included in the House bill; the ADAP Working Group, composed of AIDS advocacy groups and pharmaceutical companies, predicted in an April report that state ADAPs would need $299 mil. in federal support during fiscal 1998 ("The Pink Sheet" April 21, T&G-5).
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth